Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis

(2017) Paul Y. Kwo et al.   JOURNAL OF HEPATOLOGY

EASL Recommendations on Treatment of Hepatitis C 2016

(2017)   JOURNAL OF HEPATOLOGY

Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy

(2016) D. Banerjee et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)

(2016) Vincent Leroy et al.   HEPATOLOGY

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection

(2015) Stephen Pianko et al.   ANNALS OF INTERNAL MEDICINE

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study

(2015) David R. Nelson et al.   HEPATOLOGY

Natural prevalence of resistance-associated variants in hepatitis C virus NS5A in genotype 3a-infected people who inject drugs in Germany

(2015) Andreas Walker et al.   JOURNAL OF CLINICAL VIROLOGY

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

(2015) Graham R. Foster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

(2015) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Natural prevalence of NS5A polymorphisms in subjects infected with hepatitis C virus genotype 3 and their effects on the antiviral activity of NS5A inhibitors

(2013) Dennis Hernandez et al.   JOURNAL OF CLINICAL VIROLOGY

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis

(2011) G. Nkontchou et al.   JOURNAL OF VIRAL HEPATITIS

HCV genotype 3: An independent predictor of fibrosis progression in chronic hepatitis C

(2009) Stella De Nicola et al.   JOURNAL OF HEPATOLOGY

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C

(2009) Pierre-Yves Bochud et al.   JOURNAL OF HEPATOLOGY